About the Product

Description


Thyine 12.5 Tablet contains Thyroxine (Levothyroxine) 12.5 mcg, a synthetic form of the thyroid hormone T4 (thyroxine), essential for regulating metabolism, energy production, and overall growth and development. It is primarily used for managing hypothyroidism, a condition where the thyroid gland does not produce enough hormones, leading to symptoms like fatigue, weight gain, dry skin, hair thinning, and cold sensitivity.

Thyroxine plays a vital role in maintaining the body's metabolic rate, heart function, digestion, brain development, and muscle activity. It helps restore normal thyroid hormone levels, alleviating the symptoms of thyroid dysfunction. Additionally, it may be used in certain cases of goiter (enlarged thyroid gland), thyroid hormone replacement therapy, and thyroid disorders linked to pregnancy.

Thyine 12.5 is an essential therapy for individuals diagnosed with subclinical or mild hypothyroidism, where a slight imbalance in thyroid hormones affects metabolism. It is commonly prescribed for patients needing precise dosage adjustments to achieve optimal thyroid hormone balance without excessive stimulation.

For best results, this medication should be taken on an empty stomach, preferably in the morning, at least 30–60 minutes before breakfast, as food can interfere with absorption. Regular thyroid function tests are recommended to monitor TSH (Thyroid-Stimulating Hormone) levels and adjust the dosage accordingly.

Common side effects include palpitations, headache, sweating, nervousness, weight loss, and sleep disturbances. Overdose can lead to symptoms of hyperthyroidism.

Used to treat hypothyroidism, thyroid hormone imbalance, and associated metabolic disorders.

Take exactly as prescribed by a doctor. Do not self-adjust the dosage. Regular thyroid function monitoring is necessary for optimal treatment.

Store in a cool, dry place, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

1. What are the business opportunities for Thyroxine (Levothyroxine) 12.5 mcg Tablet in the PCD pharma franchise market?

Thyroxine (Levothyroxine) 12.5 mcg Tablet is an essential product in the endocrinology and thyroid management segment. With the rising incidence of hypothyroidism and thyroid-related disorders, this formulation has consistent and long-term prescription demand. It presents strong business opportunities for pharma franchise partners, distributors, stockists, and wholesalers across India due to its chronic therapy usage.

2. Why should medical distributors include Levothyroxine 12.5 mcg Tablet in their product range?

Medical distributors and pharma franchise companies can benefit from the steady and long-term demand for thyroid hormone replacement therapy prescribed under medical supervision. Levothyroxine 12.5 mcg is a synthetic thyroid hormone used to treat hypothyroidism Commonly prescribed by endocrinologists, physicians, and gynecologists Used as a long-term or lifelong therapy in many patients with thyroid deficiency Available in multiple dosage strengths, ensuring consistent prescription continuity Widely used in hospitals, clinics, and retail pharmacy channels Strong repeat prescription market due to chronic nature of thyroid disorders This product strengthens a comprehensive endocrinology and chronic care portfolio.

3. Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Thyroxine (Levothyroxine) 12.5 mcg Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Thyroxine (Levothyroxine) 12.5 mcg Tablet. Franchise partners receive monopoly rights, promotional support, attractive packaging, competitive pricing, and reliable supply chain assistance to help build a strong presence in the endocrinology segment.

4. What benefits do wholesalers get by partnering for this product?

Wholesalers, distributors, and medical agencies can benefit from: High and consistent demand in the thyroid therapy segment Strong repeat prescription market due to lifelong treatment requirement Regular prescriptions from endocrinologists and general physicians Attractive profit margins and stable business growth Reliable product availability and supply chain support Expansion of chronic care and endocrine product portfolio

5. How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and pharma professionals can partner with Cafoli LifeCare Pvt Ltd to market Levothyroxine (Thyroxine) 12.5 mcg Tablet across India. With exclusive monopoly-based franchise opportunities, comprehensive promotional support, quality-assured formulations, attractive business margins, competitive pricing, and dependable logistics assistance, Cafoli LifeCare Pvt Ltd helps partners build a stable and profitable pharmaceutical business in the chronic care segment.